Barclays analyst Lauren Lieberman lowered the firm’s price target on Constellation Brands to $288 from $295 and keeps an Overweight rating on the shares. The firm says that while Molson Coors (TAP) and Constellation Brands (STZ) have both “gotten swept up in a negative thesis opposite increasingly constructive sentiment” for Anheuser-Busch Inbev (BUD), the path forward is “decidedly different between the two companies.” Putting two names in the same bucket as AB Inbev is a “significant oversimplification,” the analyst tells investors in a research note. It sees a difficult path ahead for Molson, with the soft industry background exacerbating the negative operating leverage dynamics to come for the company. By contrast, Constellation’s beer business is a mid-single-digit volume grower over the medium term and Barclays has high conviction in its ability to continue to hit numbers, says the analyst.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STZ:
- Constellation Brands Announces Updated Time of Presentation at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 2024
- Constellation Brands to Present at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 2024
- Constellation Brands price target lowered to $311 from $314 at Jefferies
- Strike Alert: How Labor Unrest Could Shake Up Constellation Brands’ Operations and Finances
- Marijuana: Growth and Opportunity Amidst High Hurdles